• Bright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Analysts at Piper Sandler

    来源: Buzz FX / 23 1月 2025 06:56:18   America/Chicago


    Bright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Analysts at Piper Sandler Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Piper Sandler started coverage on shares of Bright Minds Biosciences ( NASD
    Read more...
分享